Montreal, November 29, 2016 – ZoomMed Inc. (TSX Venture Exchange: ZMD), announces it has held its Annual and Special Meeting of Shareholders on November 29, 2016.
The meeting was held for the purpose of:
- To receive the consolidated financial statements of ZoomMed for the fiscal year ended May
31, 2016 and the independent auditors’ report;
- To elect the board of directors composed of:
- Micheline Luneau
- Yves Marmet
- Nicolas Matziorinis
- Bruno Floriani
- Marie-Hélène Pinard
- Robert Powell
- To appoint Mazars Harel Drouin as the independent auditor and authorize the directors to fix their remuneration;
- To approve ZoomMed’s stock option plan, a 10% rolling stock option plan;
Shareholders voted overwhelmingly in favor of all the resolutions that were presented at that meeting.
For further information on ZoomMed, contact Mr. Yves Marmet, President and Chief Executive Officer (450) 678-5457, Ext 228, email@example.com or visit our Web Site; www.zoommed.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Statements made in this news release that are not historical facts are “forward-looking statements” and readers are cautioned that any such statements are not guarantees of future performance, and that actual developments or results, may vary materially from those in these “forward-looking” statement.